Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
about
Association between RCAS1 expression and clinical outcome in uterine endometrial cancerThe estrogen receptor joins other cancer biomarkers as a predictor of outcomeDistribution of estrogen and progesterone receptors isoforms in endometrial cancer.Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.Coordinate patterns of estrogen receptor, progesterone receptor, and Wilms tumor 1 expression in the histopathologic distinction of ovarian from endometrial serous adenocarcinomasEndometrial metastasis of colorectal cancer with coincident endometrial adenocarcinomaMolecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report.Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases.Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancerCorrelation of CD24 expression with histological grading and TNM staging of retinoblastoma.Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survivalInsights into endometrial serous carcinogenesis and progression.Predictive diagnosis of endometrial hyperplasia and personalized therapeutic strategy in women of fertile age.Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.Selected immuno-histochemical markers in curettage specimens and their correlation with final pathologic findings in endometrial cancer patients.Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.The relationship of COX-2 expression with estrogen receptor, progesterone receptor and prognostic parameters in endometrial carcinomas.Expression of p53 in imprint smears of endometrial carcinoma.Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.HOXA10 expression in endometrial adenocarcinoma.Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.Expression of immunoreactivity of nuclear findings by p53 and cyclin a in endometrial cytology: Comparison with endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.Cell cycle regulators and apoptosis-associated proteins in relation to proliferative activity and degree of apoptosis in HNPCC versus sporadic endometrial carcinoma.The influence of HK2 blood group antigen on human B cell activation for ABOi-KT conditions.Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.Hormone Receptor Expression in Spontaneous Uterine Adenocarcinoma in Fischer 344 Rats.Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma.Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma.Myoferlin Expression and Its Correlation with FIGO Histologic Grading in Early-Stage Endometrioid Carcinoma.
P2860
Q24651134-480DF836-09BA-4F84-BC47-B916140BFF91Q26865554-0B5C12F2-6950-45E9-AB88-BD9DA2224F63Q33616773-CFD7A23B-87B4-4D74-99DC-24D59805E38EQ33633962-92C19191-8CEA-404A-9469-CCEAC80CF036Q33723952-F65DA868-BE66-427B-9E39-6D7B09BE0F39Q33837822-8E91FBF7-173F-4335-890E-57457AF0C0CAQ34528152-01CF78FA-7641-463F-8557-E0692D9048D2Q34652138-1D3F559C-D2D4-4FAB-B8B7-55CEB31981E3Q35880398-9A96455E-E3BE-4AD4-A7DE-F59D14780591Q36493879-2417AFB4-3541-4694-82F6-83E871A26C2CQ36516283-821E644A-AD2A-455D-B05E-EF1042C5AE48Q36697758-899DB8D3-7305-4F3B-A76B-D255EFBE1E06Q36707726-32E16052-18BE-4BA9-85FA-FFBC0993BBFAQ37127024-86B45708-0E0D-4735-9926-1EAF8B6BDA41Q37399772-A325D930-0355-4851-A5A0-62F898498E8BQ37472835-4C2AC7D3-F503-49DA-96FA-24B636FF0B9BQ38051267-BC7889CF-0519-4274-9281-AC58C18A2940Q38648524-E8A7117F-F8E1-438E-BD0F-0DBC681346DBQ42991846-AF167F31-FBB5-49A1-BF61-67BC5A4A9F95Q43457339-6D805A95-A983-45C2-9C28-8692DF09BA0AQ44101817-FA17F4C0-4A16-4043-AC37-246E1E543F6FQ45208298-2F89341D-273D-4772-A96F-584A43D694C5Q46311812-90EFE04C-1C80-43B7-A3FB-B73845711D95Q46888711-42108393-AF3D-406A-9C32-F564BE5FDEDFQ46906781-32E4C005-47E7-439D-89F4-8DD5C860D6B0Q47137888-7CDABD84-E4CA-4450-9E28-4BD407C08705Q51006519-D3A2AB8F-FA20-46BA-A309-3FC3C6217053Q53208025-E825931E-9364-4DA2-86BC-3D858ED9F169Q54194405-0CA55EA7-367B-40CF-A23A-95ACE5B29685Q54530132-DDD1AE6F-0927-47C4-A07C-C4AC13E41431Q55332453-37758F16-ADB1-45BD-8777-0340C3F6CD12
P2860
Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunohistochemical profile of ...... and review of the literature.
@ast
Immunohistochemical profile of ...... and review of the literature.
@en
type
label
Immunohistochemical profile of ...... and review of the literature.
@ast
Immunohistochemical profile of ...... and review of the literature.
@en
prefLabel
Immunohistochemical profile of ...... and review of the literature.
@ast
Immunohistochemical profile of ...... and review of the literature.
@en
P2093
P2860
P1433
P1476
Immunohistochemical profile of ...... and review of the literature.
@en
P2093
P2860
P2888
P304
P356
10.1038/MODPATHOL.3880062
P577
2000-04-01T00:00:00Z
P5875
P6179
1020167158